>R&D >R&D Organizations >Shonan Research Center

Shonan Research Center

The Shonan Research Center is located in the cities of Fujisawa and Kamakura in Kanagawa Prefecture. The new facility integrates the Osaka and Tsukuba research centers as the nucleus of Takeda’s global research network to accelerate innovation in drug discovery. Around 1,200 researchers at the center will work through the various stages of the R&D process, from the initial search for drug discovery targets to the selection of candidate compounds.

The center combines a research environment fitted with state-of-the-art equipment and a functional layout of buildings that facilitates collaboration within each research function. Conference rooms and multi-purpose "Nomad" rooms of varying size are situated in frequent locations along the main corridor to foster free communication and sharing of knowledge that is uninhibited by organizational boundaries.

Takeda will make full use of the Shonan Research Center as a global research hub to promote open innovation. The center is to house an "Incubation Lab" scheduled for opening in the third quarter of fiscal 2011 as a facility for collaborative research with partners from outside the Company. Takeda will promote sophisticated networks with external research institutions by bringing together human resources from venture firms and academia who share a passion for drug discovery.

About Shonan Incubation Laboratories

The Shonan Incubation Laboratories are the newly launched programs in the Shonan Research Center of Takeda Pharmaceutical Company Limited.

In this program, distinguished researchers from external institutions will work side?by-side with Takeda researchers, bringing new insights to drug discovery through intensely collaborative research.

As a first step, the BC Cancer Agency’s Chair of Breast Cancer Research, Dr. Sam Aparicio, has been invited to The Center to lead this research. During the three-year new drug target exploration project, the BC Cancer Agency and Takeda will combine Dr. Aparicio's leading-edge insights into gene analysis and the BC Cancer Agency's next-generation DNA sequencing technique with Takeda's drug discovery technologies, expertise and world-class facilities.